Press Releases
August 15, 2023
IN8bio to Present at the H.C. Wainwright Immune Cell Engager Virtual Conference
August 10, 2023
IN8bio Reports Second Quarter 2023 Financial Results and Provides Corporate Update
August 8, 2023
IN8bio Expands Capabilities with the Grand Opening of its Advanced Research and Development Facility
June 5, 2023
IN8bio Announces Positive INB-200 Phase 1 Data Update in Glioblastoma at the 2023 ASCO Annual Meeting
May 17, 2023
IN8bio's DeltEx Gamma-Delta T Cells Show Promise in Targeting Ovarian Cancer